← Back to Company DatabaseVisit Website
Invitae
Affordable genetic testing for hereditary cancer and beyond.
PublicSan Francisco, CAFounded 2010
About
Invitae is a genetics company that provides affordable and accessible genetic testing for hereditary cancer syndromes and other conditions. The company offers comprehensive panels for cancer predisposition genes and somatic tumor profiling. Invitae aims to make genetic information a standard part of healthcare, including proactive cancer risk assessment.
Total Funding
$1.7BKey Product
Invitae multi-gene hereditary cancer panelsGeography
North AmericaKey Investors
Durable Capital PartnersCasdin CapitalSoftBank Vision Fund
Focus Areas
DiagnosticsEarly Detection / Screening
Technology
Genomics / Sequencing
Cancer Types
BreastColorectalPan-cancer
Last updated: Feb 4, 2026